Advertisement

Principaux indicateurs et facteurs de risque de cancer du rein

  • D. Veillard
  • A. Danzon
  • M. Velten
Chapter
  • 380 Downloads
Part of the Oncologie pratique book series (ONCOLPRAT)

Abstrait

Incidence et mortalité sont des indicateurs de la surveillance épidémiologique des cancers. Ľincidence et la mortalité mesurent respectivement la fréquence de survenue des nouveaux diagnostics et celle des décès par cancer dans une population définie. Ces mesures se présentent sous forme ďeffectifs (nombre de cas incidents ou de décès), de taux bruts (effectifs rapportés à la population étudiée) ou de taux standardisés. Les taux standardisés selon ľâge (c'est-à-dire calculés en utilisant la distribution ďune population de référence) permettent de comparer le risque de nouveau diagnostic ou de décès par cancer entre des populations ayant des structures ďâge différentes.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Tyczynski JE, Démaret E, Parkin DM (2003) Standards and guidelines for cancer registration in Europe, the ENCR recommendations, volume 1. IARC technical publication no 40. IARC press, LyonGoogle Scholar
  2. 2.
    World Health Organisation, Geneva (2000) International Classification of Diseases for Oncology, ICD-O, 3th editionGoogle Scholar
  3. 3.
    Remontet L, Estève J et al. (2003) Cancer incidence and mortality in France over the period 1978–2000. Incidence et mortalité par cancer en France de 1978 à 2000. Rev Epidemiol Santé Publique 51: 3–30PubMedGoogle Scholar
  4. 4.
    Danzon A, Langlois J, Crétarre B et al. Epidemiology of kidney parenchyma cancer in France: incidence in 2000 and estimation of prevalence in 2004: a population based study from seven cancer registries (article soumis)Google Scholar
  5. 5.
    Hollingsworth JM, Miller DC, Daignault S et al. (2006) Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 98: 1331–4PubMedCrossRefGoogle Scholar
  6. 6.
    Nguyen MM, Gill IS, Ellison LM (2006) The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol 176: 2397–400PubMedCrossRefGoogle Scholar
  7. 7.
    Estève J, Benhamou E, Raymond L (1993) Méthodes statistiques en épidémiologie descriptive. Les éditions INSERM, Paris.Google Scholar
  8. 8.
    Kaplan ES, Meier P (1958) Non-parametric estimation from incomplete observation. Am Stat Assoc J 53: 457–80CrossRefGoogle Scholar
  9. 9.
    Cox DR (1972) Regression models and life tables. J R Stat Soc B 34: 187–220Google Scholar
  10. 10.
    Capocaccia R, Gatta G, Roazzi P et al. (2003) The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 14 Suppl 5: v14–27PubMedCrossRefGoogle Scholar
  11. 11.
    Velten M, Grosclaude P (2007) Survie des patients atteints de cancer en France. Étude des registres du réseau FRANCIM. Springer-Verlag France, ParisGoogle Scholar
  12. 12.
    Sant M, Aareleid T, Berrino F et al. (2003) EUROCARE 3: survival of cancer patients diagnosed 1990–1994 results and commentary. Ann Oncol 14 Suppl 5: 61–118CrossRefGoogle Scholar
  13. 13.
    McLaughlin JK, Lipworth L, Tarone RE et al. (2006) Epidemiologic aspects of renal cell carcinoma. Semin Oncol 33: 527–33PubMedCrossRefGoogle Scholar
  14. 14.
    Rhote R, Thiounn N, Debré B et al. (2004) Risk factors for adult renal cell carcinoma. Urol Clin North Am 31: 237–47CrossRefGoogle Scholar
  15. 15.
    Fu H, Boffetta P (1995) Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup Environ Med 52: 73–81PubMedCrossRefGoogle Scholar
  16. 16.
    Hunt JD, van der Hel OL, McMillan GP et al. (2005) Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114: 101–8PubMedCrossRefGoogle Scholar
  17. 17.
    Goodman M, Morgan RW, Ray R et al. (1999) Cancer in asbestos-exposed occupational cohorts: a meta-analysis. Cancer Causes Control 10: 453–65PubMedCrossRefGoogle Scholar
  18. 18.
    Sali D, Boffetta P (2000) Kidney cancer and occupational exposure to asbestos: a meta-analysis of occupational cohort studies. Cancer Causes Control 11: 37–47PubMedCrossRefGoogle Scholar
  19. 19.
    Linehan WM, Walther MM, Zbar B et al. (2003) The genetic basis of cancer of the kidney. J Urol 170: 2163–72PubMedCrossRefGoogle Scholar
  20. 20.
    Van Houwelingen KP, van Dijk BA, Hulsbergen-van de Kaa CA et al. (2005) Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. BMC Cancer 5: 57PubMedCrossRefGoogle Scholar
  21. 21.
    Bergstrom A, Hsieh CC, Lindblad P et al. (2001) Obesity and renal cells cancer-a quantitative review. Br J Cancer 85: 984–90PubMedCrossRefGoogle Scholar
  22. 22.
    Chow WH, Gridley G, Fraumeni JF Jr et al. (2000) Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 343: 1305–11PubMedCrossRefGoogle Scholar
  23. 23.
    Bjorge T, Tretli S, Engeland A (2004) Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 160: 1168–76PubMedCrossRefGoogle Scholar
  24. 24.
    Flaherty KT, Fuchs CS, Colditz GA et al. (2005) A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control 16: 1099–106PubMedCrossRefGoogle Scholar
  25. 25.
    Fryzek JP, Poulsen AH, Johnsen SP et al. (2005) A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer 92: 1302–6PubMedCrossRefGoogle Scholar
  26. 26.
    McLaugllin JK, Lipworth L (2000) Epidemiologic aspects of renal cell cancer. Semin Oncol 27: 115–23Google Scholar
  27. 27.
    Stewart JH, Buccianti G, Agodoa L et al. (2003) Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14: 197–207PubMedCrossRefGoogle Scholar
  28. 28.
    Cuckovic C, L. Djukanovic, Jankovic S et al. (1996) Malignant tumors in hemodialysis patients Nephron 73: 710–2PubMedCrossRefGoogle Scholar
  29. 29.
    Vamvakas S, Bahner U, Heidland A (1998) Cancer in end-stage renal disease: potential factors involved-editorial. Am J Nephrol 18: 89–95PubMedCrossRefGoogle Scholar
  30. 30.
    Rashidkhani B, Lindblad P, Wolk A (2005) Fruits, vegetables and risk of renal cell carcinoma: a prospective study of Swedish women. Int J Cancer 113: 451–5PubMedCrossRefGoogle Scholar
  31. 31.
    Van Dijk BA, Schouten LJ, Kiemeney LA et al. (2005) Vegetable and fruit consumption and risk of renal cell carcinoma: results from the Netherlands cohort study. Int J Cancer 117: 648–54PubMedCrossRefGoogle Scholar
  32. 32.
    Bravi F, Bosetti C, Scotti L et al. (2007) Food groups and renal cell carcinoma: a case-control study from Italy. Int J Cancer 120: 681–5PubMedCrossRefGoogle Scholar
  33. 33.
    Wolk A, Lindblad P, Adami HO et al. (1992) Nutrition and renal cell cancer. Cancer Causes Control 7: 5–18CrossRefGoogle Scholar
  34. 34.
    Adami HO, McLaughlin JK, Hsing AW et al. (1992) Alcoholism and cancer risk: a population-based cohort study. Cancer Causes Control 3: 419–25PubMedCrossRefGoogle Scholar
  35. 35.
    Lee JE, Giovannucci E, Smith-Warner SA et al. (2006) Total fluid intake and use of individual beverages and risk of renal cell cancer in two large cohorts. Cancer Epidemiol Biomarkers Prev 15: 1204–11PubMedCrossRefGoogle Scholar
  36. 36.
    Lindblad P, Mellemgaard A, Schlehofer B et al. (1995) International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer 61: 192–8PubMedCrossRefGoogle Scholar
  37. 37.
    Gago-Dominguez M, Castelao JE et al. (1999) Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev 8: 999–1003PubMedGoogle Scholar
  38. 38.
    Pairon JP, Borchard P, Le Bourgeois JP et al. Les cancers professionnels: tome I (2000, 688 pages) et tome II (2001, 580 pages). Editions Margaux Orange, ParisGoogle Scholar
  39. 39.
    Parent ME, Hua Y et al. (2000) Occupational risk factors for renal cell carcinoma in Montreal. Am J Ind Med 38: 609–18PubMedCrossRefGoogle Scholar
  40. 40.
    Zhang Y, Cantor KP, Lynch CF et al. (2004) A population-based case-control study of occupation and renal cell carcinoma risk in Iowa. J Occup Environ Med 46: 235–40PubMedCrossRefGoogle Scholar
  41. 41.
    Partanen T, Heikkila P et al. (1991) Renal cell cancer and occupational exposure to chemical agents. Scand J Work Environ health 17: 231–9PubMedGoogle Scholar
  42. 42.
    Mandel JS, McLaughlin JK et al. (1995) International renal-cell cancer study. IV. Occupation. Int J Cancer 61: 601–5PubMedCrossRefGoogle Scholar
  43. 43.
    Pesch B, Haerting J, Ranft U et al. (2000) Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int J Epidemiol 29: 1014–24PubMedCrossRefGoogle Scholar
  44. 44.
    Bruning T, Pesch B, Wiesenghutter B et al. (2003) Renal cell cancer risk and occupational exposure to trichloroethylene: results of a consecutive case-control study in Arnsberg, Germany. Am J Ind Med 43: 274–85PubMedCrossRefGoogle Scholar
  45. 45.
    Charbotel B, Fevotte J, Hours M et al. (2006) Case-control study on renal cell cancer and occupational exposure to trichloroethylene. Part II: Epidemiologic aspects. Ann Occup Hyg 50: 777–87PubMedCrossRefGoogle Scholar
  46. 46.
    Fevotte J, Charbotel B, Muller-Beaute P et al. (2006) Case-control study on renal cell cancer and occupational exposure to trichloroethylene. Part I: Exposure assessment. Ann Occup Hyg 50: 765–75PubMedCrossRefGoogle Scholar
  47. 47.
    Raaschou-Nielsen O, Hansen J, Thomsen BL et al. (2002) Exposure of Danish workers to trichloroethylene, 1947–1989. Appl Occup Environ Hyg 17: 693–703PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France, Paris 2008

Authors and Affiliations

  • D. Veillard
    • 1
  • A. Danzon
    • 2
    • 3
  • M. Velten
    • 3
    • 4
  1. 1.Service ďépidémiologie et de santé publiqueHôpital Pontchaillou-CHU de RennesRennes cedexFrance
  2. 2.Registre des tumeurs du DoubsCHU Saint JacquesBesançon cedex
  3. 3.Réseau français des registres de cancer FRANCIM Faculté de médecineUnité Inserm 558Toulouse cedexFrance
  4. 4.Laboratoire ďépidémiologie et de santé Publique Registre des cancers du Bas-Rhin Faculté de médecineUniversité Louis PasteurStrasbourg

Personalised recommendations